+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sinusitis Drugs Market 2024-2028

  • PDF Icon

    Report

  • 178 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5304738
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sinusitis drugs market is forecasted to grow by USD 735.7 million during 2023-2028, accelerating at a CAGR of 5.53% during the forecast period. The report on the sinusitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions among vendors.

The sinusitis drugs market is segmented as below:

By Product

  • Steroid nasal sprays
  • Antibiotics
  • Decongestants
  • Others

By Disease Type

  • Acute sinusitis
  • Chronic sinusitis
  • Sub-acute sinusitis

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing investments in research and development by major players as one of the prime reasons driving the sinusitis drugs market growth during the next few years. Also, advent of biologics and technological advances in sinusitis drugs will lead to sizable demand in the market.

The report on the sinusitis drugs market covers the following areas:

  • Sinusitis drugs market sizing
  • Sinusitis drugs market forecast
  • Sinusitis drugs market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sinusitis drugs market vendors that include AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Inc., DR Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Neopharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teligent Inc., and Teva Pharmaceutical Industries Ltd. Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Sinusitis Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Sinusitis Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Disease Type segment analysis 2018 - 2022
Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Steroid nasal sprays - Market size and forecast 2023-2028
Chart on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million)
Data Table on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million)
Chart on Steroid nasal sprays - Year-over-year growth 2023-2028 (%)
Data Table on Steroid nasal sprays - Year-over-year growth 2023-2028 (%)
6.4 Antibiotics - Market size and forecast 2023-2028
Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
6.5 Decongestants - Market size and forecast 2023-2028
Chart on Decongestants - Market size and forecast 2023-2028 ($ million)
Data Table on Decongestants - Market size and forecast 2023-2028 ($ million)
Chart on Decongestants - Year-over-year growth 2023-2028 (%)
Data Table on Decongestants - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Disease Type
7.1 Market segments
Chart on Disease Type - Market share 2023-2028 (%)
Data Table on Disease Type - Market share 2023-2028 (%)
7.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
7.3 Acute sinusitis - Market size and forecast 2023-2028
Chart on Acute sinusitis - Market size and forecast 2023-2028 ($ million)
Data Table on Acute sinusitis - Market size and forecast 2023-2028 ($ million)
Chart on Acute sinusitis - Year-over-year growth 2023-2028 (%)
Data Table on Acute sinusitis - Year-over-year growth 2023-2028 (%)
7.4 Chronic sinusitis - Market size and forecast 2023-2028
Chart on Chronic sinusitis - Market size and forecast 2023-2028 ($ million)
Data Table on Chronic sinusitis - Market size and forecast 2023-2028 ($ million)
Chart on Chronic sinusitis - Year-over-year growth 2023-2028 (%)
Data Table on Chronic sinusitis - Year-over-year growth 2023-2028 (%)
7.5 Sub-acute sinusitis - Market size and forecast 2023-2028
Chart on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million)
Data Table on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million)
Chart on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%)
Data Table on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product/Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd. - Overview
Alembic Pharmaceuticals Ltd. - Product/Service
Alembic Pharmaceuticals Ltd. - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
12.7 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
12.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.9 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.11 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.12 Neopharma Corp.
Neopharma Corp. - Overview
Neopharma Corp. - Product/Service
Neopharma Corp. - Key offerings
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product/Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Sinusitis Drugs Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Product - Market share 2023-2028 (%)
Exhibits 33: Data Table on Product - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Product
Exhibits 35: Data Table on Comparison by Product
Exhibits 36: Chart on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Steroid nasal sprays - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Steroid nasal sprays - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Steroid nasal sprays - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Decongestants - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Decongestants - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Decongestants - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Decongestants - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Product ($ million)
Exhibits 53: Data Table on Market opportunity by Product ($ million)
Exhibits 54: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits 55: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Disease Type
Exhibits 57: Data Table on Comparison by Disease Type
Exhibits 58: Chart on Acute sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Acute sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Acute sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Acute sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Chronic sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Chronic sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Chronic sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Chronic sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Sub-acute sinusitis - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Sub-acute sinusitis - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Disease Type ($ million)
Exhibits 71: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ million)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: AbbVie Inc. - Overview
Exhibits 122: AbbVie Inc. - Product/Service
Exhibits 123: AbbVie Inc. - Key news
Exhibits 124: AbbVie Inc. - Key offerings
Exhibits 125: Alembic Pharmaceuticals Ltd. - Overview
Exhibits 126: Alembic Pharmaceuticals Ltd. - Product/Service
Exhibits 127: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits 128: Bayer AG - Overview
Exhibits 129: Bayer AG - Business segments
Exhibits 130: Bayer AG - Key news
Exhibits 131: Bayer AG - Key offerings
Exhibits 132: Bayer AG - Segment focus
Exhibits 133: Dr Reddys Laboratories Ltd. - Overview
Exhibits 134: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 135: Dr Reddys Laboratories Ltd. - Key news
Exhibits 136: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 137: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 138: Fresenius SE and Co. KGaA - Overview
Exhibits 139: Fresenius SE and Co. KGaA - Business segments
Exhibits 140: Fresenius SE and Co. KGaA - Key news
Exhibits 141: Fresenius SE and Co. KGaA - Key offerings
Exhibits 142: Fresenius SE and Co. KGaA - Segment focus
Exhibits 143: GlaxoSmithKline Plc - Overview
Exhibits 144: GlaxoSmithKline Plc - Business segments
Exhibits 145: GlaxoSmithKline Plc - Key news
Exhibits 146: GlaxoSmithKline Plc - Key offerings
Exhibits 147: GlaxoSmithKline Plc - Segment focus
Exhibits 148: Hikma Pharmaceuticals Plc - Overview
Exhibits 149: Hikma Pharmaceuticals Plc - Business segments
Exhibits 150: Hikma Pharmaceuticals Plc - Key news
Exhibits 151: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 152: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 153: Johnson and Johnson Services Inc. - Overview
Exhibits 154: Johnson and Johnson Services Inc. - Business segments
Exhibits 155: Johnson and Johnson Services Inc. - Key news
Exhibits 156: Johnson and Johnson Services Inc. - Key offerings
Exhibits 157: Johnson and Johnson Services Inc. - Segment focus
Exhibits 158: Merck and Co. Inc. - Overview
Exhibits 159: Merck and Co. Inc. - Business segments
Exhibits 160: Merck and Co. Inc. - Key news
Exhibits 161: Merck and Co. Inc. - Key offerings
Exhibits 162: Merck and Co. Inc. - Segment focus
Exhibits 163: Neopharma Corp. - Overview
Exhibits 164: Neopharma Corp. - Product/Service
Exhibits 165: Neopharma Corp. - Key offerings
Exhibits 166: Novartis AG - Overview
Exhibits 167: Novartis AG - Business segments
Exhibits 168: Novartis AG - Key news
Exhibits 169: Novartis AG - Key offerings
Exhibits 170: Novartis AG - Segment focus
Exhibits 171: Pfizer Inc. - Overview
Exhibits 172: Pfizer Inc. - Product/Service
Exhibits 173: Pfizer Inc. - Key news
Exhibits 174: Pfizer Inc. - Key offerings
Exhibits 175: Sanofi SA - Overview
Exhibits 176: Sanofi SA - Business segments
Exhibits 177: Sanofi SA - Key news
Exhibits 178: Sanofi SA - Key offerings
Exhibits 179: Sanofi SA - Segment focus
Exhibits 180: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 181: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 182: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 183: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 184: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 185: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 186: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 187: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 188: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 189: Inclusions checklist
Exhibits 190: Exclusions checklist
Exhibits 191: Currency conversion rates for US$
Exhibits 192: Research methodology
Exhibits 193: Information sources
Exhibits 194: Data validation
Exhibits 195: Validation techniques employed for market sizing
Exhibits 196: Data synthesis
Exhibits 197: 360 degree market analysis
Exhibits 198: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global sinusitis drugs market: AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Inc., Dr Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Neopharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teligent Inc., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing investments in research and development by major players."

According to the report, one of the major drivers for this market is the rising prevalence of sinusitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Alembic Pharmaceuticals Ltd.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Bionpharma Inc.
  • CHIESI Farmaceutici SpA
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Neopharma Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teligent Inc.
  • Teva Pharmaceutical Industries Ltd.